Learn to Move 0-2 years: Early intervention in children with cerebral palsy

ISRCTN ISRCTN52740878
DOI https://doi.org/10.1186/ISRCTN52740878
Secondary identifying numbers 60-61300-98-003
Submission date
09/09/2008
Registration date
19/09/2008
Last edited
11/02/2009
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Nervous System Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Mijna Hadders-Algra
Scientific

PO Box 30001
Groningen
9713 GZ
Netherlands

Study information

Study designRandomised single-blind controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific title
Study acronymL2M0-2
Study objectivesOne year of intervention with the new physiotherapeutic programme COPCA (see Interventions) results in a better motor developmental outcome than one year of intervention by means of traditional paediatric physiotherapy in infants at very high risk for cerebral palsy.
Ethics approval(s)Added 11/02/2009: Medical Ethics Committee of the University Medical Centre Groningen gave approval on the 24th October 2008 (ref: METc2008.176)
Health condition(s) or problem(s) studiedCerebral palsy
InterventionCOPCA = "COPing with and CAring for infants with neurological dysfunction" programme:
The COPCA programme is a home based programme, and will be delivered by specially trained paediatric physiotherapists. The COPCA programme has motor and educational goals.

The motor goals:
a. To increase the infant's motor repertoire
b. To improve the ability to select a specific strategy fit for function in a specific daily life situation

Educational goals:
a. Promotion/restoration of intuitive parenting capacities, which in general are seriously affected in caregivers of infants with neurological disability
b. Coaching family members in such a way that they are able to cope well with life, including the developmental problems of the child

Schedule of the COPCA programme: 1 hour/session, 2 sessions per week for the first 6 months, and then 1 session every 2 weeks for the next 6 months (total duration of the programme: 1 year)

Description of the COPCA programme can be found at: http://www.ncbi.nlm.nih.gov/pubmed/17555816

The participants in the control group will receive traditional paediatric physiotherapy for 1 year.
Intervention typeOther
Primary outcome measureScore on the Infant Motor Profile (IMP) at baseline, after 3, 6 and 12 months after start of intervention.
Secondary outcome measures1. Neurological condition, assessed at 3, 6 and 12 months
2. Alberta Infant Motor Scale (AIMS), assessed at 3, 6 and 12 months
3. Gross Motor Function Measure (GMFM), assessed at 3, 6 and 12 months
4. Bayley Scales of Infant Development (BSID), assessed at 3, 6 and 12 months
5. Vineland Adaptive Behavior Scales (VABS), assessed at 6 and 12 months
6. Pediatric Evaluation of Disability Inventory (PEDI), assessed at 12 months
7. Nijmeegse Ouderlijke Stress Index (NOSI-K), assessed at 12 months
8. Utrecht Coping List (UCL), assessed at 12 months
9. Family Empowerment Scale (FES), assessed at 6 and 12 months
10. Measure of Processes Of Care (MPOC), assessed at 12 months
Overall study start date01/01/2009
Completion date31/12/2012

Eligibility

Participant type(s)Patient
Age groupChild
Lower age limit3 Months
Upper age limit9 Months
SexBoth
Target number of participants40 (2 groups of 20 children)
Key inclusion criteria1. Both males and females, corrected age at enrolment 3 to 9 months
2. At very high risk for cerebral palsy (CP), based on the presence of one of the following:
a. Cystic periventricular leukomalacia (PVL), diagnosed on serial ultrasound assessment of the brain
b. Uni- or bilateral parenchymal lesion of the brain
c. Term/near term asphyxia resulting in Sarnat 2 or 3 with brain lesions on magnetic resonance imaging (MRI) and/or neurological dysfunction during infancy suggesting the development of CP
d. Neurological dysfunction suggestive of development of CP
Key exclusion criteria1. Caregivers have insufficient understanding of the Dutch language
2. Infants who have an additional severe congenital disorder, such as a serious congenital heart disorder
Date of first enrolment01/01/2009
Date of final enrolment31/12/2012

Locations

Countries of recruitment

  • Netherlands

Study participating centre

PO Box 30001
Groningen
9713 GZ
Netherlands

Sponsor information

The Netherlands Organisation for Health Research and Development (ZonMw) (Netherlands)
Research organisation

Laan van Nieuw Oost Indië 33
Den Haag
2509 AE
Netherlands

Phone +31 (0)70 349 51 11
Email info@zonmw.nl
Website http://www.zonmw.nl
ROR logo "ROR" https://ror.org/01yaj9a77

Funders

Funder type

Research organisation

The Netherlands Organisation for Health Research and Development (ZonMw) (Netherlands) (ref: 60-61300-98-003, thema II [kinderen])

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan